Base editing has a delivery problem. The editing machinery—a fusion protein and guide RNA—must reach the right cells in the right tissue, and delivery methods are still evolving. Viral vectors, lipid nanoparticles, and other approaches are being tested, each with trade-offs. Delivery is one of the biggest challenges facing the base editing market, and solving it is essential for...
